chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Beginning at 11pm - chills, headache, nausea, muscle aches, sleeplessness, anxiety, high blood pressure, pulse 100+ . Syptoms lasted until 3pm the following day. Seemed to improve after taking benadryl. Aleve did not help.
Swelling on right side of neck; Bump right up on collar bone of neck/Bump between thumb and index finger of right hand/Mushy bump/Painful bump in finger; Swelling on hand; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling on right side of neck), KERATOSIS PILARIS (Bump right up on collar bone of neck/Bump between thumb and index finger of right hand/Mushy bump/Painful bump in finger) and PERIPHERAL SWELLING (Swelling on hand) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included LEVOTHYROXINE, ATORVASTATIN, CHLORTHALIDONE, EZETIMIBE, GABAPENTIN, LOSARTAN, MAGNESIUM OXIDE, METOPROLOL, MULTIVITAMINS [VITAMINS NOS], POTASSIUM CHLORIDE and TICAGRELOR (BRILINTA) for an unknown indication.    On 21-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced SWELLING (Swelling on right side of neck), KERATOSIS PILARIS (Bump right up on collar bone of neck/Bump between thumb and index finger of right hand/Mushy bump/Painful bump in finger) and PERIPHERAL SWELLING (Swelling on hand). At the time of the report, SWELLING (Swelling on right side of neck), KERATOSIS PILARIS (Bump right up on collar bone of neck/Bump between thumb and index finger of right hand/Mushy bump/Painful bump in finger) and PERIPHERAL SWELLING (Swelling on hand) outcome was unknown.            Treatment information was not provided.
diagnosed with Shingles; This is a spontaneous report received from Salelytics from a contactable consumer or other non hcp.  A female patient of an unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced diagnosed with shingles on an unspecified date. Clinical outcome of the event shingles was unknown.  No follow-up attempts are possible. No further information is expected.
Per mother, within 24 hrs onset of fever and loose stools.  Fever of 102 noted at home.  Pt brought to ER and assessed.  Parents advised to continue Tylenol and follow up with clinic if needed.
This spontaneous report was received from a Licensed practical nurse (L.P.N) regarding an unknown number of patients of unknown age and unknown gender. No medical history and concurrent conditions were reported. On 19-NOV-2015, 22-NOV-2015, 25-NOV-2015 and 01-DEC-2015, patients were vaccinated with improperly stored oral, ROTATEQ (dose number, anatomical location frequency and route unknown) with lot # L026740 (expiry date 16-APR-2017) and lot number # L000571 (expiry date 26-JUL-2016) (incorrect product storage). However, the L.P.N. was not aware of which was administered to which patient. Concomitant medications of the patient were unknown. No other adverse events were reported. No product quality complaint was reported. This is one of the several reports from the same reporter. Additional information has been requested.
After receiving my second dose of the Pfizer COVID-19 Vaccine on the morning of 1/13/21, I had arm soreness at the injection site. Later in the day, I experienced fatigue, which progressed to body chills and aches. Overnight, I developed a fever of 101.5 F. Fever was managed with  ibuprofen taken throughout the following day, 1/13/21. On 1/13/21 at night, I had another fever of 101.6 F but did not taken any antipyretics before bed. On the morning 1/14/21 body aches, body chills, and fevers were resolved without antipyretics. Arm soreness still present on 1/14/21.
progressive distal>proximal bilat LE & UE numbness & weakness, loss of reflexes;on day #8-9 p/some bilat facial nerve palsy;no further progression p/then IV IG given;dx by neurologist=probable GBS;
101 fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101 fever) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PYREXIA (101 fever). At the time of the report, PYREXIA (101 fever) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature: 101 (Inconclusive) 101 fever.         No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Significant pain, tingling and numbness in fingers. Unable to raise arm since vaccination without significant pain.
Patient said needle got stuck in her arm, and RPH had a hard time getting it out. Now patient says she has blood clot in her arm 2 week later.
Polyneuropathy in bilateral legs, headache, and weakness 24 hours after first dose of Pfizer with worsening over subsequent 48 hours - currently being admitted to hospital for evaluation.
Upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe.; Upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe.; Upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POOR QUALITY PRODUCT ADMINISTERED (non-serious), DEVICE BREAKAGE (non-serious), DEVICE LEAKAGE (non-serious) and all described as "Upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe.". Additional information: The reporter had two syringes fail from the Abrysvo. Upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe. Causality for "upon mixing the product and attempting to draw up, the neck of the syringe must have been cracked or breached because it leaked all over out of the side of the neck of the syringe." was determined associated to device constituent of rsv vaccine prot.subunit pref 2v (malfunction). The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Patient presented as a transfer to our facility for Myopericarditis. He had received 2nd covid vaccine on Friday (5/7/21), subsequently had mild body aches the next day that improved with otc Tylenol. On sunday night he started to develop mild chest pain. Monday morning his pain acutely worsened with 8/10 chest pain, shortnes of breath, and emesis x1. He was ultimately found to have myopericaridits after being transferred to our facility for cardiac MRI. His troponin peaked at 5.71, had no pericardial effuison, and normal EF. Pain well controlled with colchicine and ibuprofen.  After 2 days of observation he was discharged home. He did not have any viral prodrome or illness recently, no hx of family hx of rheumatological conditions.
Patient had 2 1/2x 1 1/2 in red, swollen area with lump to right arm
Client complain of dizziness, chest pain and hard to breath.  Seen by EMS, took vitals signs no further treatment required. Stayed for 30 min , left building in no distress accompanied by mother.
Lower body purpura, petechiae and bruising. Swelling of (L) hand and knees. Dx: HSP (Henoch-Schonlein Purpura).
Second Moderna vaccine -  Slept for 17 hours, body aches and chills  - Within 24 hours of the vaccine.  Day 2 still tired but able to function
Swollen, red, hot, taut skin, onset 1/3/21, rx cephalaxin 7 days
Shortness of breath, fatigue, chilis and sweats, headache, weight loss, sore arm injection site, racing heart, nausea, achiness.
After HPV vaccine patient had syncopal episode and fell off of exam table and sustained traumatic injury to nose. Sent to ER for evaluation.
Systemic: Chills-Medium, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Severe, Systemic: Shakiness-Mild, Systemic: Weakness-Severe, Additional Details: Pt passed out about 4 minutes after 2nd Pfizer dose given.  I had her lie down and she remained that way for close to 30 minutes.  She finally was able to sit up, drink some water, and waited 15 more minutes and then was able to leave
Pt experienced burning in left arms since 2nd vaccination of Anthrax. The pt also experienced swelling, redness, diarrhea, and tired for 2 weeks.
Arm swollen; black and blue bruise; small lump under the skin; This is a spontaneous report from a contactable (patient). A 59-year-old non-pregnant female patient received first dose BNT162B2 (solution for injection, Batch/Lot number and expiry date was not reported, age at vaccination: 59-year-old), via an unspecified route of administration, in Arm Left on 03Mar2021 02:30 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included ginkgo biloba leaf (GINKO BILOBA [GINKGO BILOBA LEAF]) and vitamins. The patient previously had codeine, dilaudid, and morphine allergies. On 03Mar2021 03:00, the patient experienced arm swollen, black and blue bruise and small lump under the skin. The patient did not receive any corrective treatment. The patient did not receive any other vaccine in four weeks. The patient was not tested positive for covid prior and post vaccination. The outcome of events was recovered.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained
Moderna COVID-19 Vaccine EUA. Fever temperature at 103 degrees, joint discomfort, muscle aches, skin sensitivity in arms and shoulders. Took Tylenol and rested one day. Today, after four days, there are still some muscle aches, even though minimal.
Pt felt pain immediately. She first went to Dr. 2 wks after receiving shot. She was given Prednisone at that time. She reports she is still in significant pain & has done a second round of prednisone.
pt recv vax 29JUN95 & 25FEB97 pt devel chickenpox;
Date and time are estimated. Body aches and joint pain in arms and legs. Rash developed on left leg, side, and stomach area. Rash cleared after about a month, joint pain remains. Had hand pain and developed trigger finger in 2 fingers of both hands within 2 months of vaccination. Taking TYLENOL 325 mg twice a day seems to help some.
pain at the injection site; feeling dizzy; This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 71-year-old female patient who received Herpes zoster (Shingrix) (batch number 4RF5J, expiry date 25th April 2022) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced injection site pain and dizziness. On an unknown date, the outcome of the injection site pain and dizziness were recovered/resolved.   It was unknown if the reporter considered the injection site pain and dizziness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. After the administration of Shingrix vaccine, the patient started feeling dizzy, condition lasted for a week and presented pain at the injection site the same day of the administration. The reporter did not consent to follow-up.
Swelling at site of reaction with Twinrix 02/08/2006.   03/09/2006 some induration and small areas of scabbing at center.  Area was not hot to touch and there was no active drainage.  Patient experienced fever and diarrhea on the afternoon of the injection and off and on for 3 days there after.  Patient says site of injection opened several days after the injection and drained only bloody drainage without pus, then closed, and then opened again with some type of drainage, and healed over.
Approximately 11 days after receiving her first dose of Pfizer BioNTech Covid-19 she woke up with noticeably decreased hearing. She went to an audiologist and also an autolaryngologist. Both are concerned this may having something to do with either having antibodies for Covid-19 or having had the vaccine.
FLUMIST on 8/28/2009 (2nd exposure to...first FLUMIST given in 9/2008 w/o reaction). Approximately 15 minutes after receipt of 8/2009 FLUMIST she had slightly raised red dots to face that spread to her neck/face/chest area. She had some mild itching and felt hot. She denied any n/v, shortness of breath, swelling, dysphagia, chest pain, or any other systemic symptom. She was seen at ER being diagnosed with allergic reaction and treated with oral BENADRYL. She advised symptoms resolved within 30 minutes and have never recurred.
Pain in arm for first two days after vaccine booster. Itching/hives all over body for several days following booster. Patient previously received J&J vaccine in June with no side effects.
Persistent pain at injection site/muscle, lasted since second injection. Patient stated that normally soreness from injection of vaccine last couple of days but not this time. Treated it with ice/OTC pain meds like ADVIL but pain still exist.
Information has been received from a registered nurse (R.N.) concerning a 13-month-old female who about 10 days prior to the adverse experienced, on approximately 06-MAY-2006, was vaccinated with a dose of Varivax at the health department. On 16-MAY-2006 the patient developed an erythematous rash, with a vesicular papule by her right nipple with a few barely raised tiny papules on her abdomen and fading papules on her right arm. No lesions were scabbed. She was seen in the physician's office on 16-MAY-2006. It was noted that it may have been a possible reaction to the vaccine. The patient's mother was told to call if the rash increased or worsened. No outcome was reported. Additional information has been requested.
Mild pain on left arm; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 13Apr2021 at 16:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Apr2021 at 17:00, the patient experienced mild pain on left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of mild pain on left arm was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Arm is really sore; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm is really sore) and HEADACHE (Slight headache) in a 73-year-old male elderly exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) , while the parent received the product for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant product exposures included TRAMADOL, FLUOXETINE, POTASSIUM and IBUPROFEN for an unknown indication.    On 24-Mar-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 24-Mar-2021, the elderly was diagnosed with VACCINATION SITE PAIN (Arm is really sore) and HEADACHE (Slight headache). The Elderly was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, VACCINATION SITE PAIN (Arm is really sore) and HEADACHE (Slight headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: TCR: AE outcome
Patient given COVID-19 vaccine 07/26/2022 that expired on 06/30/2022. No symptoms reported.
Products were not good and needed to be returned with no reported; Poor quality vaccine administered with no reported adverse event; Initial information was received on 19-Apr-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case is linked to case 2023SA129826.  This case involves Infant and unknown gender patient who involved in the products HIB (PRP/T) VACCINE [ACT-HIB] were not good and needed to be returned and poor quality vaccine administered with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received 0.5 ml dose of suspect products HIB (PRP/T) vaccine Powder and solvent for solution for injection (lot UJ756AAA, expiry date: 12-Aug-2023, strength, route administrative site: Unknown) for prophylactic vaccination (immunization).  On an unknown date the patient developed a non-serious products were not good and needed to be returned with no reported (product storage error) and poor quality vaccine administered with no reported adverse event (poor quality product administered) (latency: same day) following the administration of HIB (PRP/T) VACCINE.  No lab data reported.  Action taken: not applicable.  Outcome: Unknown for both the event products.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Migratory Joint Pain for 2 weeks; Paresthesia for 2 weeks.
pt recv vax 29AUG97 & 9SEP97 pt exp rash on chest that consisted of approx 10 maculopapular lesions w/vesicles;10SEP97 pt was seen by primary hlth care;
Pt reports developing itching and non-draining rash on 11/9/00, that has continued to today. Itching and rash is only on left shoulder and upper back, no pustules noted. On his own, pt began taking OTC Benadryl on 11/16/00. Pt has also used rubbing alcohol and Vaseline lotion on rash with little relief.
Shivering; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Shivering) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced CHILLS (Shivering). At the time of the report, CHILLS (Shivering) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included Reflux medication and Ashtma medication when needed. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-090371, US-MODERNATX, INC.-MOD-2021-090451 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up document added 27-May-2021 contains non significant information; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090371:Son's case US-MODERNATX, INC.-MOD-2021-090451:Dose 2 case
This spontaneous report as received from a doctor of pharmacy refers to a 89 years old female patient. The patient's medical history included cancer survivor of 2 years. The patient was vaccinated with subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot # H016765; exp date 12-OCT-2013) on 13-DEC-2012. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that for the first 15 minutes after the administration of the dose, her injection site was itching and red. The pharmacist who administered the dose documented that the site was raised and red in a quarter sized perimeter. On 14-DEC-2012 the patient reported to the pharmacist that the injection site was "no longer raised, but it was light pink." No treatment information was reported. The outcome of injection site was itching and red was reported as recovering. The relatedness for the reported events was not provided for ZOSTAVAX. Additional information has been requested.
Patient is reporting her adverse events; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patient is reporting her adverse events) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient is reporting her adverse events). At the time of the report, VACCINATION COMPLICATION (Patient is reporting her adverse events) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  The treatment information was  not provided.
Moderna Covid-19 vaccine results in delayed suspected hypersensitivity rash the following morning after the injection involving her left arm that the shot was given, spread to her back, chest, groin that was fixed rash that persisted for 12 days.  It was itchy, red rash without pain and then became dried spots.  Rash resolved with some post hyperpigmentation.  No prior history of rash or URI symptoms. Empiric treatment with valacyclovir without relief.  Minor reolif with antihistamaine.  Dermatology telederm suspect folliculitis, exanthem, bites, atypical varicella zoster versus delayed T cell rash after vaccine so did not get 2nd dose and received Johnson and Johnson vaccine instead  5/13